Lipoprotein lipase deficiency with pancreatitis in mink: Biochemical characterization and pathology

Journal of Lipid Research

Volumn 38, Issue 5, 1997, Pages 837-846

  Christophersen, Björn ^a   Nordstoga, Knut ^b,c   Shen, Yan ^d   Olivecrona, Thomas ^d   Olivecrona, Gunilla ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c UMEÅ UNIVERSITY   (Sweden)

^d NONE

Author keywords

Heparin Sepharose; Hepatic lipase; Lipase monomer; Type I hyperlipoproteinemia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTRIGLYCERIDEMIA; LIPOGRANULOMA; LIPOPROTEIN METABOLISM; MALE; MINK; NONHUMAN; PANCREATITIS; POINT MUTATION; PRIORITY JOURNAL;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; MINK; PANCREATITIS;

EID: 0030982084     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Chait, A., and J. D. Brunzell. 1992. Chylomicronemia syndrome. Adv. Intern. Med. 37: 249-273.
2. Fojo, S. S. 1992. Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein C-II. Curr. Opin. Lipidol. 3: 186-195.
3. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic and Molecular Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York. 1913-1932.
4. Baggio, G., E. Manzato, C. Gabelli, R. Fellin, S. Martini, G. B. Enzi, F. Verlato, M. R., Baiocchi, D. L. Sprecher, M. L. Kashyap, H. B. Brewer, Jr., and G. Crepaldi, 1986. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J. Clin. Invest. 77: 520-527.
5. Lewis, M. E. S., I. J. Forsythe, J. D. Marth, J. D. Brunzell, M. R. Hayden, and R. K. Humphries. 1995. Retroviral-mediated gene transfer and expression of human lipoprotein lipase in somatic cells. Hum. Gene Ther. 6: 853-863.
6. Zilversmit, D. B. 1973. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ. Res. 33: 633-638.
7. Zilversmit, D. B. 1995. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41: 153-158.
8. Olivecrona, G., and T. Olivecrona. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6: 291-305.
9. Jones, B. R., A. Wallace, D. R. Harding, W. S. Hancock, and C. H. Campbell. 1983. Occurrence of idiopathic, familial hyperchylomicronaemia in a cat. Vet. Rec. 112: 543-547.
10. Jones, B. R., A. C. Johnstone, J. I. Cahill, and W. S. Hancock. 1986. Peripheral neuropathy in cats with inherited primary hyperchylomicronaemia. Vet. Rec. 119: 268-272.
11. Thompson, J. C., A. C. Johnstone, B. R. Jones, and W. S. Hancock. 1989. The ultrastructural pathology of five lipoprotein lipase-deficient cats. J. Comp. Pathol. 101: 251-262.
12. Peritz, L. N., J. D. Brunzell, C. Harvey-Clarke, P. H. Pritchard, B. R. Jones, and M. R. Hayden. 1990. Characterization of a lipoprotein lipase class III type defect in hypertriglyceridemic cats. Clin. Invest. Med. 13: 259-263.
13. Ginzinger, D. G., M. E. S. Lewis, Y. H. Ma, B. R. Jones, G. Q. Liu, S. D. Jones, and M. R. Hayden. 1996. A mutation in the lipoprotein lipase gene is the molecular basis of chylomicronemia in a colony of domestic cats. J. Clin. Invest. 97: 1257-1266.
14. Coleman, T., R. L. Seip, J. M. Gimble, D. Lee, N. Maeda, and C. F. Semenkovich. 1995. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J. Biol. Chem. 270: 12518-12525.
15. Paterniti, J. R. J., W. V. Brown, H. N. Ginsberg, and K. Artzt. 1983. Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science. 221: 167-169.
16. Olivecrona, T., S. S. Chernick, G. Bengtsson-Olivecrona, J. R. Paterniti, Jr., W. V. Brown, and R. O. Scow. 1985. Combined lipase deficiency (cld/cld) in mice: demonstration that an inactive form of lipoprotein lipase is synthesized. J. Biol. Chem. 260: 2552-2557.
17. Masuno, H., E. J. Blanchette-Mackie, S. S. Chernick, and R. O. Scow. 1990. Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured brown adipocytes of combined lipase-deficient cld/cld mice. J. Biol. Chem. 265: 1628-1638.
18. Nordstoga, K., G., N. Havre, and G. Loftsgaard. 1990. Hyperchylomicronaemia in mink - a preliminary communication. Scientifur. 14: 219.
19. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
20. Iverius, P-H. 1971. Coupling of glycosaminoglycans to agarose beads (Sepharose 4B). Biochem. J. 124: 677-683.
21. Bengtsson-Olivecrona, G., and T. Olivecrona. 1992. Assay of lipoprotein lipase and hepatic lipase. In Lipoprotein Analysis: a Practical Approach. C. A. Converse and E. R. Skinner, editors. Oxford University Press, New York. 169-185.
22. Vilella, E., J. Joven, M. Fernández, S. Vilaró, J. D. Brunzell, T. Olivecrona, and G. Bengtsson-Olivecrona. 1993. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J. Lipid Res. 34: 1555-1564.
23. Tornvail, P., G. Olivecrona, F. Karpe, A. Hamsten, and T. Olivecrona. 1995. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15: 1086-1093.
24. Karpe, F., G. Steiner, T. Olivecrona, L. A. Carlson, and A. Hamsten. 1993. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 91: 748-758.
25. Olivecrona, G., M. Hultin, R. Savonen, N. Skottova, A. Lookene, Y. Tugrul, and T. Olivecrona. 1995. Transport of lipoprotein lipase in plasma and lipoprotein metabolism. In Atherosclerosis X. F. P. Woodford, J. Davignon, and A. Sniderman, editors. Elsevier, Amsterdam, The Netherlands. 250-253.
26. Bergö, M., G. Olivecrona, and T. Olivecrona. 1996. Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting. Biochem. J. 313: 893-898.
27. Babirak, S. P., P-H. Iverius, W. Y. Fujimoto, and J. D. Brunzell. 1989. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis. 9: 326-334.
28. Buscà, R., M. A. Pujana, P. Pognonec, J. Auwerx, S. S. Deeb, M. Reina, and S. Vilaró. 1995. Absence of N-glycosylation at asparagine 43 in human lipoprotein lipase induces its accumulation in the rough endoplasmic reticulum and alters this cellular compartment. J. Lipid Res. 36: 939-951.
29. Hata, A., D. N. Ridinger, S. D. Sutherland, M. Emi, L. K. Kwong, J. Shuhua, A. Lubbers, B. Guy-Grand, A. Basdevant, P-H. Iverius, D. E. Wilson, and J-M. Lalouel. 1992. Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization. J. Biol. Chem. 267: 20132-20139.
30. 9 → Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler. Thromb. 15: 468-478.
31. Krapp, A., H. F. Zhang, D. Ginzinger, M. S. Liu, A. Lindberg, G. Olivecrona, M. R. Hayden, and U. Beisiegel. 1995. Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells. J. Lipid Res. 36: 2362-2373.
32. Johnstone, A. C., B. R. Jones, J. C. Thompson, and W. S. Hancock. 1990. The pathology of an inherited hyperlipoproteinemia of cats. J. Comp. Pathol. 102: 125-137.
33. Benlian, P., J. L. de Gennes, L. Foubert, H. Zhang, S. E. Gagne, and M. Hayden. 1996. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335: 848-854.